PriceSensitive

Avicanna (TSX:AVCN) and Harrington Wellness launching re+PLAY branded CBD products in Canada

Cannabis
TSX:AVCN
20 December 2021 09:15 (EST)

Source: Harrington Wellness

Avicanna (AVCN) and partner Harrington Wellness are introducing the re+PLAY sports recovery-based CBD brand to Canadian consumers.

Harrington Wellness was founded by NBA veteran Al Harrington.

re+PLAY is a performance-based CBD wellness brand built with the fundamentals and combined knowledge of scientists, athletes, doctors, and certified athletic trainers.

Avicanna and Harrington Wellness have worked together on the research, development, and optimization of these CBD-based topicals inspired by the athletic and sports community. These CBD-based topicals utilize Avicanna’s proprietary technology for cannabinoid delivery and have been curated with the support of Harrington Wellness’ understanding of the needs of professional athletes.

“We’re very excited to work with our partners at Avicanna to bring our powerful line of performance recovery based topicals to Canada,” stated Al Harrington, CEO of Harrington Wellness.

The products are now available across adult use channels in Alberta and are expected to launch across Canada in Q1 2022. These products will also be available to patients through medical channels in partnership with Medical Cannabis by Shoppers nationwide in early January.

“We are thrilled to be expanding our wellness product offerings within the Canadian marketplace and to be introducing the first sports focused THC-Free line of functional products. This line has been curated through this world class partnership with the Harrington Wellness team and been in development since 2019.”

re+PLAY is a performance and recovery-based CBD brand that delivers the natural and powerful benefits of CBD through advanced formulations. The line is THC-Free and endorsed by doctors and used by both professional athletes and certified athletic trainers. re+PLAY was founded by NBA Veteran Al Harrington, renowned trainer Joe Abunasser and Dr. Sanford Kunkel, the team physician for both the Indiana Pacers and the USA national basketball team.

Avicanna is a Canadian commercial-stage biopharmaceutical company established in cannabinoid research, development, and evidence-based products for the global consumer, as well as medical and pharmaceutical market segments.

Avicanna Inc. (AVCN) opened trading at C$0.75 per share.

Related News